View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Pembrolizumab 400, Tumor Biomarker Defined
Protocol-ID: 1286 V1.0 (Mini), PEMB400, Tumor Biomarker DefinedIndication(s)
- Tumor Biomarker Defined (Mismatch Repair - deficient / Microsatellite Instability - high (dMMR/MSI-H))
Links
- Pembrolizumab [EMA EPAR]
- Pembrolizumab (Keytruda) FDA HIGHLIGHTS OF PRESCRIBING INFORMATION [URL]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 14.08.2019